Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-04958242 In Healthy Volunteers
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
This study aims to assess the safety, tolerability, and pharmacokinetics of PF-04958242 at a number of single ascending doses in healthy volunteers
Key facts
- Study ID
- NCT02228395
- Run by
- Biogen
- People needed
- 12
- Starts
- 2014-09-22
- Expected to finish
- 2014-11-13
- Last updated by the study team
- 2020-01-07
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- New Haven Clinical Research Unit — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.